Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
Conditions: End-stage Kidney Disease; Kidney Disease, Chronic; Dialysis; Diabetic; Non-diabetic; Kidney Dysfunction; Kidney Failure; Hemodialysis Interventions: Drug: Empagliflozin; Other: Placebo Sponsors: University of Utah; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Dialysis | Empagliflozin | Endocrinology | Hemodialysis | Jardiance | Research | Urology & Nephrology